Bile Acid Malabsorption, Primary
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1
|
3
|
0.710 |
limited |
1.000 |
1 |
3
|
1997 |
1997 |
Pelvic Cancer
|
disease |
Neoplasms
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Watery diarrhoea
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
5
|
1
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Neonatal alloimmune thrombocytopenia (NAIT)
|
disease |
|
Disease or Syndrome
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Bile acid malabsorption
|
disease |
Digestive System Diseases; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
9
|
|
0.040 |
None |
1.000 |
4 |
|
2001 |
2017 |
Hyperlipoproteinemia Type IV
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
11
|
3
|
0.020 |
None |
0.500 |
2 |
|
2000 |
2001 |
Esophageal dysplasia
|
disease |
Digestive System Diseases; Neoplasms
|
Disease or Syndrome
|
13
|
2
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Cholestatic pruritus
|
phenotype |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Sign or Symptom
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Erythroblastosis, Fetal
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
16
|
1
|
0.010 |
None |
1.000 |
1 |
|
1995 |
1995 |
Neonatal Alloimmune Thrombocytopenia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
29
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Progressive intrahepatic cholestasis (disorder)
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
31
|
10
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Steatorrhea
|
phenotype |
Digestive System Diseases; Nutritional and Metabolic Diseases
|
Finding
|
37
|
|
0.100 |
None |
|
0 |
|
|
|
Cholestasis, progressive familial intrahepatic 1
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
38
|
19
|
0.020 |
None |
1.000 |
2 |
|
2004 |
2014 |
Gilbert Disease (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
40
|
29
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Ileitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
44
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Biliary calculi
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Body Substance
|
48
|
31
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Intrahepatic Cholestasis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
54
|
3
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Chronic diarrhea
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
62
|
9
|
0.100 |
None |
|
0 |
|
|
|
Polyp of large intestine
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
99
|
32
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Necrotizing Enterocolitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
103
|
7
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Organic Mental Disorders, Substance-Induced
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Prescription Drug Abuse
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Finding
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Adenomatous Polyps
|
disease |
Neoplasms
|
Neoplastic Process
|
120
|
20
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Drug Use Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
121
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Substance-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
128
|
20
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |